Guan J, Yang Q, Chen C, Wang G, Zhu H. Prognostic value of low skeletal muscle mass in hepatocellular carcinoma patients treated with sorafenib or lenvatinib: A meta-analysis. EXCLI J. [Internet]. 2021 Jan. 4 [cited 2024 Apr. 20];20:1-16. Available from: https://www.excli.de/index.php/excli/article/view/3111